Trabecular micro-bypass implant (iStent®) in a case of bilateral acute depigmentation of the iris

ABSTRACT We report a case of bilateral acute depigmentation of the iris in which satisfactory intraocular pressure control was obtained after resolution of the acute disease with a trabecular implant (iStent®). A 62-year-old woman presented with bilateral simultaneous acute eye pain, photophobia, in...

Full description

Saved in:
Bibliographic Details
Published inArquivos brasileiros de oftalmologia Vol. 87; no. 3
Main Authors Maestrini, Heloisa Andrade, Maestrini, Angela Andrade, Cenachi, Sarah Pereira de Freitas, Massote, José Aloisio, Lopes, Amanda Batista, Fernandes, Thatiana Almeida Pereira
Format Journal Article
LanguagePortuguese
Published Conselho Brasileiro de Oftalmologia 2024
Subjects
OPHTHALMOLOGY
Cataract
Hipertensão ocular
Doenças da íris
Gonioscopia
Ocular hypertension
Gonioscopy
Stents
Iris disease
Catarata
Online AccessGet full text

Cover

More Information
Summary:ABSTRACT We report a case of bilateral acute depigmentation of the iris in which satisfactory intraocular pressure control was obtained after resolution of the acute disease with a trabecular implant (iStent®). A 62-year-old woman presented with bilateral simultaneous acute eye pain, photophobia, increased intraocular pressure (34 mmHg), circulating pigment in the anterior chamber, areas of depigmentation in the iris, and posterior synechiae. She had received oral amoxicillin-clavulanate and moxifloxacin for pneumonia 2 months previously. Bilateral acute depigmentation of the iris was suspected as well as a viral etiology. She received oral acetazolamide, aciclovir, and prednisone, besides topical prednisolone, betaxolol, brimonidine, dorzolamide, and atropine. The disease gradually resolved in 4 months but, after 1 year, she developed bilateral cataracts, and still needed three drugs for intraocular pressure control (16/18 mmHg). Cataract-iStent® combined surgery was performed in both eyes. One year after surgery, intraocular pressure was 11/12 mmHg, without medication. iStent® was safe and effective on this secondary glaucoma.
ISSN:1678-2925
DOI:10.5935/0004-2749.2021-0239